We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 189 results
  1. Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway

    Background

    Prostate cancer (PCa) is becoming the most common malignancy in men worldwide. We investigated the effect of astragaloside IV combined with...

    Xujun You, Junfeng Qiu, ... Wei Fu in BMC Cancer
    Article Open access 15 April 2024
  2. Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1

    Background

    Astragaloside IV (AS-IV) is one of the basic components of Astragali radix , that has been shown to have preventive effects against various...

    Yuanzhang Zhu, Fei Lu in BMC Cancer
    Article Open access 04 June 2024
  3. Blockade of PI3K/AKT signaling pathway by Astragaloside IV attenuates ulcerative colitis via improving the intestinal epithelial barrier

    Background

    The specific pathogenesis of UC is still unclear, but it has been clear that defects in intestinal barrier function play an important role...

    **nhui Zhang, Fan Zhang, ... Xun Jiang in Journal of Translational Medicine
    Article Open access 30 April 2024
  4. Astragaloside IV-mediated inhibition of oxidative stress by upregulation of ghrelin in type 2 diabetes–induced cognitive impairment

    This study is to observe the upregulation effect of astragaloside IV on ghrelin in diabetic cognitive impairment (DCI) rats and to investigate the...

    Rui-hua Zhang, Shan-shan Cao, ... Ji-** Liu in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 25 April 2023
  5. Astragaloside IV Inhibits Rotenone-Induced α-syn Presentation and the CD4 T-Cell Immune Response

    The increased α-synuclein (α-syn)-dependent activation of CD4 T cells leads to the progressive loss of dopaminergic (DA) neurons in the substantia...

    Mengdi Wang, Fengjiao Sun, ... Hongcai Wang in Molecular Neurobiology
    Article 21 August 2023
  6. Nrf2 knockout attenuates the astragaloside IV therapeutic effect on kidney fibrosis from liver cancer by regulating pSmad3C/3L pathways

    Fibrotic kidney injury from hepatocarcinogenesis seriously impacts treatment effect. Astragaloside IV (AS-IV), an extract of Astragalus membranaceus,...

    Qin Wang, Jiacheng Xu, ... Yan Yang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 15 September 2023
  7. Metabolomics combined with network pharmacology reveals a role for astragaloside IV in inhibiting enterovirus 71 replication via PI3K-AKT signaling

    Background

    Astragaloside IV (AST-IV), as an effective active ingredient of Astragalus membranaceus (Fisch.) Bunge. It has been found that AST-IV...

    **Fang Hao, **aoyan Zhang, ... Qingshan Li in Journal of Translational Medicine
    Article Open access 10 June 2024
  8. Chitosan/Polylactic Acid Nanofibers Containing Astragaloside IV as a New Biodegradable Wound Dressing for Wound Healing

    The ideal wound dressing should adequately protect the wound from bacterial infection and provide a suitable healing environment for the wound. Thus,...

    Zemei Liu, Yuanju Lv, ... **n Che in AAPS PharmSciTech
    Article 02 October 2023
  9. Astragaloside IV suppresses migration and invasion of TGF-β1-induced human hepatoma HuH-7 cells by regulating Nrf2/HO-1 and TGF-β1/Smad3 pathways

    Astragaloside IV (AS-IV), one of the major compounds extract from Astragalus membranaceus, has shown attractive anti-cancer effects in certain...

    Lili Li, Qin Wang, ... **aonan Pang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 29 January 2022
  10. Protective effects of Astragaloside IV against oxidative injury and apoptosis in cultured astrocytes by regulating Nrf2/JNK signaling

    Ischemic stroke is a worldwide complex brain disease that results in numerous disabilities and deaths. It leads to the deprivation of oxygen and...

    **tao Yang, Chongyu Shao, ... Jiehong Yang in Experimental Brain Research
    Article 08 April 2021
  11. Astragaloside IV Exerts Anti-tumor Effect on Murine Colorectal Cancer by Re-educating Tumor-Associated Macrophage

    Astragaloside IV (AS-IV) has shown anti-tumorigenic properties in certain cancers for its effect of boosting the body’s immune system, but its role...

    Feng Liu, Fang Ran, ... Linyun Chen in Archivum Immunologiae et Therapiae Experimentalis
    Article 23 October 2020
  12. Astragaloside IV inhibits astrocyte senescence: implication in Parkinson’s disease

    Background

    Senescent astrocytes have been implicated in the aging brain and neurodegenerative disorders, including Parkinson’s disease (PD)....

    Mei-Ling **a, **a-Hong **e, ... Gang Hu in Journal of Neuroinflammation
    Article Open access 06 April 2020
  13. Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1

    Astragaloside IV (ASV), which has several pharmacological abilities, shows potential therapeutic effects on certain cancers by regulating the...

    Shufang Hu, Weihong Zheng, Li ** in Journal of Natural Medicines
    Article 20 November 2020
  14. Astragaloside IV and echinacoside benefit neuronal properties via direct effects and through upregulation of SOD1 astrocyte function in vitro

    Amyotrophic lateral sclerosis (ALS), also known as a major type of motor neuron disease, is a disease characterized by the degeneration of both upper...

    Yang Tian, Shijie **, ... Yunling Zhang in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 20 November 2020
  15. Effect of astragaloside IV on indoxyl sulfate-induced kidney injury in mice via attenuation of oxidative stress

    Background

    Astragalus membranaceus , a traditional Chinese medicine (TCM), has been widely used in the treatment of chronic kidney disease (CKD) in...

    Chunlan Ji, Yueming Luo, ... Zhaoyu Lu in BMC Pharmacology and Toxicology
    Article Open access 03 September 2018
  16. Astragaloside IV Inhibits Cigarette Smoke-Induced Pulmonary Inflammation in Mice

    The aim of this study was to investigate the effects of Astragaloside IV (AS) on cigarette smoke (CS)-induced chronic obstructive pulmonary disease...

    Zhou Meiqian, Zhuo Leying, Cai Chang in Inflammation
    Article 29 June 2018
  17. Herbal Approaches for the Management of Neurological Disorders

    Neurological disorder like epilepsy, Alzheimer’s, and Parkinson’s disease is manifested by extensive morbidity, disability, along high rate of...
    Chapter 2023
  18. Pharmacokinetics Comparison, Intestinal Absorption and Acute Toxicity Assessment of a Novel Water-Soluble Astragaloside IV Derivative (Astragalosidic Acid, LS-102)

    Background and Objectives

    Astragaloside IV (AGS IV) is the most important bioactive constituent of Radix Astragali. However, its disappointing...

    Lin-Sen Qing, Ting-Bo Chen, ... Li-Sheng Ding in European Journal of Drug Metabolism and Pharmacokinetics
    Article 12 October 2018
  19. Monomeric compounds from natural products for the treatment of pulmonary fibrosis: a review

    Pulmonary fibrosis (PF) is the end stage of lung injury and chronic lung diseases that results in diminished lung function, respiratory failure, and...

    Zhuqing Li, Yanyong Yang, Fu Gao in Inflammopharmacology
    Article 09 May 2024
Did you find what you were looking for? Share feedback.